With the news that both the first German bid has concluded and that Macedonia seems poised to import cannabis into the European Union, there has been increased interest in who can import cannabis into Germany, if not the EU and beyond.
Could Switzerland become a major source of cannabinoid medications in Europe? The International Cannabis Business Conference in Zurich will have the latest on these rapid developments across the European continent as experts converge to discuss the latest and network to help move the industry forward.
To fully know the answer about Swiss imports, we must unravel the myriad of rules, regulations and trade agreements that entangle governmental entities across global borders. According to the European Medicines Agency, Mutual Recognition of Good Manufacturing Process (GMP) agreements now exist with Australia, Canada, Israel, Japan, New Zealand, Switzerland and of course the United States.
MRAs allow EU authorities and their counterparts to rely on each other’s GMP inspection system, share information on inspections and quality defects and waive batch testing of products that are imported.
Read more at internationalcbc.com
